Thetford Mines, August 28, 2018 – KDA Group Inc. (TSXV: KDA) (“KDA Group” or the “Corporation”) announced on June 1st, 2018 an agreement with ZoomMed Inc. (TSXV: ZMD) (“ZoomMed”) whereby KDA Group could have obtained the rights to distribute, under a non-exclusive license, the ZRx Prescriber developed by ZoomMed in the United States.